Printer's No. PN3839
See other bills
under the
same topic PRINTER'S NO. 3839 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2749 Session of 2026 INTRODUCED BY HANBIDGE, WAXMAN, POWELL, SANCHEZ AND D. WILLIAMS, AUGUST 25, 2026 REFERRED TO COMMITTEE ON HEALTH, AUGUST 25, 2026 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for drug overdose medication.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 13.8(e), (f) and (h) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, are amended and the section is amended by adding a subsection to read:Section 13.8. Drug Overdose Medication.--* * *(e) (1) A licensed health care professional who, acting in good faith, prescribes or dispenses an opioid antagonist or an expired opioid antagonist shall not be subject to any criminal or civil liability or any professional disciplinary action for:12345678910111213141516171819202122 (i) such prescribing or dispensing; or(ii) any outcomes resulting from the eventual administration of the opioid antagonist.(2) The immunity under paragraph (1) shall not apply to a health professional who acts with intent to harm or with reckless indifference to a substantial risk of harm.(f) (1) A person, law enforcement agency, fire department or fire company under subsection (b)(2) or (c) who, acting in good faith and with reasonable care, administers an opioid antagonist or an expired opioid antagonist to another person whom the person believes to be suffering an opioid-related drug overdose:(i) Shall be immune from criminal prosecution, sanction under any professional licensing statute and civil liability for such act.(ii) Shall not be subject to professional review for such act.(iii) Shall not be liable for any civil damages for acts or omissions resulting from such act.(2) Receipt of training and instructional materials that meet the criteria of subsection (a) and the prompt seeking of additional medical assistance shall create a rebuttable presumption that the person acted with reasonable care in administering an opioid antagonist.(f.1) A municipality, local health department or community-based organization that provides or distributes an expired opioid antagonist shall not be subject to any criminal or civil liability for:(1) the dispensing or provision of the expired opioid antagonist under this section; or20260HB2749PN3839 - 2 - 123456789101112131415161718192021222324252627282930 (2) any outcomes resulting from the eventual administration of the expired opioid antagonist.* * *(h) As used in this section, the [term "opioid antagonist" means a] following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:"Expired opioid antagonist" means an opioid antagonist that has an expiration date that is less than five years from the date of use."Municipality" means a city, borough, incorporated town or township."Opioid antagonist" means a drug or device approved by the Federal Food, Drug, and Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) for emergency reversal of known or suspected opioid overdose, including naloxone hydrochloride or other similarly acting drugs approved by the United States Food and Drug Administration for the treatment of an opioid overdose.Section 2. This act shall take effect in 60 days.20260HB2749PN3839 - 3 - 12345678910111213141516171819
under the
same topic PRINTER'S NO. 3839 THE GENERAL ASSEMBLY OF PENNSYLVANIAHOUSE BILL No.2749 Session of 2026 INTRODUCED BY HANBIDGE, WAXMAN, POWELL, SANCHEZ AND D. WILLIAMS, AUGUST 25, 2026 REFERRED TO COMMITTEE ON HEALTH, AUGUST 25, 2026 AN ACTAmending the act of April 14, 1972 (P.L.233, No.64), entitled "An act relating to the manufacture, sale and possession of controlled substances, other drugs, devices and cosmetics; conferring powers on the courts and the secretary and Department of Health, and a newly created Pennsylvania Drug, Device and Cosmetic Board; establishing schedules of controlled substances; providing penalties; requiring registration of persons engaged in the drug trade and for the revocation or suspension of certain licenses and registrations; and repealing an act," further providing for drug overdose medication.The General Assembly of the Commonwealth of Pennsylvania hereby enacts as follows:Section 1. Section 13.8(e), (f) and (h) of the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, are amended and the section is amended by adding a subsection to read:Section 13.8. Drug Overdose Medication.--* * *(e) (1) A licensed health care professional who, acting in good faith, prescribes or dispenses an opioid antagonist or an expired opioid antagonist shall not be subject to any criminal or civil liability or any professional disciplinary action for:12345678910111213141516171819202122 (i) such prescribing or dispensing; or(ii) any outcomes resulting from the eventual administration of the opioid antagonist.(2) The immunity under paragraph (1) shall not apply to a health professional who acts with intent to harm or with reckless indifference to a substantial risk of harm.(f) (1) A person, law enforcement agency, fire department or fire company under subsection (b)(2) or (c) who, acting in good faith and with reasonable care, administers an opioid antagonist or an expired opioid antagonist to another person whom the person believes to be suffering an opioid-related drug overdose:(i) Shall be immune from criminal prosecution, sanction under any professional licensing statute and civil liability for such act.(ii) Shall not be subject to professional review for such act.(iii) Shall not be liable for any civil damages for acts or omissions resulting from such act.(2) Receipt of training and instructional materials that meet the criteria of subsection (a) and the prompt seeking of additional medical assistance shall create a rebuttable presumption that the person acted with reasonable care in administering an opioid antagonist.(f.1) A municipality, local health department or community-based organization that provides or distributes an expired opioid antagonist shall not be subject to any criminal or civil liability for:(1) the dispensing or provision of the expired opioid antagonist under this section; or20260HB2749PN3839 - 2 - 123456789101112131415161718192021222324252627282930 (2) any outcomes resulting from the eventual administration of the expired opioid antagonist.* * *(h) As used in this section, the [term "opioid antagonist" means a] following words and phrases shall have the meanings given to them in this subsection unless the context clearly indicates otherwise:"Expired opioid antagonist" means an opioid antagonist that has an expiration date that is less than five years from the date of use."Municipality" means a city, borough, incorporated town or township."Opioid antagonist" means a drug or device approved by the Federal Food, Drug, and Cosmetic Act (52 Stat. 1040, 21 U.S.C. § 301 et seq.) for emergency reversal of known or suspected opioid overdose, including naloxone hydrochloride or other similarly acting drugs approved by the United States Food and Drug Administration for the treatment of an opioid overdose.Section 2. This act shall take effect in 60 days.20260HB2749PN3839 - 3 - 12345678910111213141516171819
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.